Profile
Huw M.
Nash was the founder of Rein Therapeutics, Inc. since 2001, holding the title of Vice President-Corporate Development from 2001 to 2013.
Dr. Nash is currently a Venture Partner at Petrichor Scion Therapeutics Management LLC since 2024.
Former positions include Chief Executive Officer at Stoke Therapeutics, Inc. from 2014 to 2017 and VP-External Collaborations & Founding Scientist at NeoGenesis Pharmaceuticals, Inc. from 1997 to 2005.
Education includes a doctorate from Harvard University and an undergraduate degree from Harvard College.
Huw Nash active positions
| Companies | Position | Start |
|---|---|---|
Petrichor Scion Therapeutics Management LLC
Petrichor Scion Therapeutics Management LLC Investment ManagersFinance Petrichor Scion Therapeutics Management LLC is an active manager. | Private Equity Investor | 01/10/2024 |
Former positions of Huw Nash
| Companies | Position | End |
|---|---|---|
| REIN THERAPEUTICS INC. | Founder | 01/01/2013 |
NeoGenesis Pharmaceuticals, Inc.
NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Used to discover and develop small molecule drugs | Corporate Officer/Principal | 01/01/2005 |
| STOKE THERAPEUTICS, INC. | Chief Executive Officer | 01/10/2017 |
Training of Huw Nash
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
NeoGenesis Pharmaceuticals, Inc.
NeoGenesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Used to discover and develop small molecule drugs | Health Technology |
Rein Therapeutics, Inc.
Rein Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops stapled peptide drugs | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stoke Therapeutics, Inc.
Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
Petrichor Scion Therapeutics Management LLC
Petrichor Scion Therapeutics Management LLC Investment ManagersFinance Petrichor Scion Therapeutics Management LLC is an active manager. | Finance |
- Stock Market
- Insiders
- Huw Nash
















